Gary W. Herschman, Anjana D. Patel, and Timothy (Tim) C. McHale,  Health Care Mergers and Acquisitions attorneys, in the firm’s Newark office, were quoted in Bloomberg Health Law & Business, in “Health-Care Dealmaking Slows as US Inflation Hits Record High,” by Christopher Brown.

Following is an excerpt:

Health-care dealmaking decreased in May under the pressure of record-setting inflation.

The number of completed or announced mergers and acquisitions was 154 in the month, down from 176 in April. The May total also marked a sharp drop from January, which saw 274 transactions.

Overall economic trends and supply chain issues point to a slowdown in transaction activity in many areas of the economy, but the health-care industry has unique characteristics that could support robust deal volume, said Gary Herschman of Epstein Becker & Green in Newark, N.J.

These include a large amount of “dry powder” in the hands of investors, and the sector’s tendency to be recession-proof, he said.

“This could result in increased health-care transaction activity in the short-term as investors may seek to utilize funds for acquisitions before interest rates potentially spike much higher over the next 12 months or more,” Herschman said.

The busiest sectors in May were life sciences, medical devices, health-care IT, and physicians services, each of which easily surpassed 100 deals so far in 2022 and are likely to lead the pack through the rest of the year, analysts say. …

Health IT

Deal volume in the healthcare IT and software sector remained strong despite national and global economic trends, said Anjana Patel of Epstein Becker & Green.

“Investors continue to see huge potential long-term windfalls from investing in technology capable of delivering and monitoring care across multiple virtual settings,” she said.

Deal volume for home-health and hospice transactions dipped in May, but overall investor interest remains strong due to expected demand from an aging population, she said. …

One notable deal in the subsector was the announced $255 million acquisition by CONMED Corp. of In2Bones Global Inc., an international maker of medical devices designed to treat extremity injuries, said Timothy McHale of Epstein Becker & Green.

Related reading:

ETFTrends, "Despite Recent Weakness, Fundamentals Still Strong for Healthcare."

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.